← All trials
NCT04077580
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2019
- Primary completion
- Dec 31, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 400
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OsloLead sponsor
- Utrecht UniversityCollaborator
- Utrecht UniversityOverall official - principal investigator
- Free University of AmsterdamCollaborator
- Free University of AmsterdamOverall official - principal investigator
- University of GothenburgCollaborator
- University of OsloReponsible party - principal investigator
- Vastra Gotaland RegionOverall official - principal investigator
- Medical University of LodzOverall official - principal investigator
- Medical University of LodzCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.